Moyra Lawrence
Cited by
Cited by
Lateral thinking: how histone modifications regulate gene expression
M Lawrence, S Daujat, R Schneider
Trends in Genetics 32 (1), 42-56, 2016
NANOG-dependent function of TET1 and TET2 in establishment of pluripotency
Y Costa, J Ding, TW Theunissen, F Faiola, TA Hore, PV Shliaha, ...
Nature 495 (7441), 370-374, 2013
Transfer to the clinic: refining forward programming of hPSCs to megakaryocytes for platelet production in bioreactors
AL Evans, A Dalby, HR Foster, D Howard, AK Waller, M Taimoor, ...
Blood Advances 5 (7), 1977-1990, 2021
CRLF3 plays a key role in the final stage of platelet genesis and is a potential therapeutic target for thrombocythemia
C Bennett, M Lawrence, JA Guerrero, S Stritt, AK Waller, Y Yan, ...
Blood, The Journal of the American Society of Hematology 139 (14), 2227-2239, 2022
Using genome editing to engineer universal platelets
M Lawrence, A Mueller, C Ghevaert
Emerging Topics in Life Sciences 3 (3), 301-311, 2019
Process analysis of pluripotent stem cell differentiation to megakaryocytes to make platelets applying European GMP
M Lawrence, A Evans, T Moreau, M Bagnati, M Smart, E Hassan, J Hasan, ...
NPJ Regenerative Medicine 6 (1), 27, 2021
ZMYM2 inhibits NANOG-mediated reprogramming
M Lawrence, TW Theunissen, P Lombard, DJ Adams, JCR Silva
Wellcome Open Research 4, 2019
Mapping the biogenesis of forward programmed megakaryocytes from induced pluripotent stem cells
M Lawrence, A Shahsavari, S Bornelöv, T Moreau, R McDonald, ...
Science Advances 8 (7), eabj8618, 2022
Human iPS cells for clinical applications and cellular products
M Lawrence
Human iPSC-derived Disease Models for Drug Discovery, 3-27, 2023
Advances in stem cell biology: induced pluripotent stem cells—novel concepts iPSC-derived megakaryocytes
M Lawrence, C Ghevaert
Recent Advances in iPSC-Derived Cell Types, 49-67, 2021
Producing megakaryocytes from iPSCs at GMP grade for clinical-grade platelet production
M Lawrence, A Mueller, T Moreau, A Evans, S Mookerjee, A Dalby, ...
HUMAN GENE THERAPY 30 (2), A3-A4, 2019
Characterisation of the inhibition of Nanog-mediated reprogramming by Zfp198, a conserved Nanog-binding partner
M Lawrence
University of Cambridge, 2015
The system can't perform the operation now. Try again later.
Articles 1–12